GRANITE Trademark

Trademark Overview

On Wednesday, April 18, 2018, a trademark application was filed for GRANITE with the United States Patent and Trademark Office. The USPTO has given the GRANITE trademark a serial number of 87882746. The federal status of this trademark filing is REGISTERED as of Tuesday, June 28, 2022. This trademark is owned by Gritstone Oncology, Inc.. The GRANITE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

healthcare

Conducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients
granite

General Information

Serial Number87882746
Word MarkGRANITE
Filing DateWednesday, April 18, 2018
Status700 - REGISTERED
Status DateTuesday, June 28, 2022
Registration Number6775104
Registration DateTuesday, June 28, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 27, 2018

Trademark Statements

Goods and Serviceshealthcare
Goods and ServicesConducting evaluations in the field of pharmaceuticals; pharmaceutical product development and evaluation services; pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; scientific research services, namely, collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; providing scientific analysis in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 26, 2018
Primary Code042
First Use Anywhere DateSaturday, September 17, 2016
First Use In Commerce DateSaturday, September 17, 2016
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 26, 2018
Primary Code044
First Use Anywhere DateMonday, March 18, 2019
First Use In Commerce DateMonday, March 18, 2019

Trademark Owner History

Party NameGRITSTONE BIO, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameGRITSTONE BIO, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameGritstone Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameGritstone Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Tuesday, June 28, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 28, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, May 21, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, May 20, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NON-FINAL ACTION E-MAILED
Friday, February 11, 2022SU - NON-FINAL ACTION - WRITTEN
Tuesday, January 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, January 21, 2022USE AMENDMENT FILED
Friday, January 21, 2022TEAS STATEMENT OF USE RECEIVED
Friday, September 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 2, 2021SOU EXTENSION 5 GRANTED
Thursday, July 22, 2021SOU EXTENSION 5 FILED
Wednesday, September 1, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 12, 2021NOTICE OF REVIVAL - E-MAILED
Wednesday, August 11, 2021EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, August 11, 2021PETITION TO REVIVE-GRANTED
Wednesday, August 11, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, June 23, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021SOU EXTENSION 4 GRANTED
Thursday, January 21, 2021SOU EXTENSION 4 FILED
Thursday, January 21, 2021TEAS EXTENSION RECEIVED
Wednesday, August 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 15, 2020SOU EXTENSION 3 GRANTED
Wednesday, July 15, 2020SOU EXTENSION 3 FILED
Wednesday, July 15, 2020TEAS EXTENSION RECEIVED
Saturday, December 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 12, 2019SOU EXTENSION 2 GRANTED
Thursday, December 12, 2019SOU EXTENSION 2 FILED
Thursday, December 12, 2019TEAS EXTENSION RECEIVED
Wednesday, March 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 25, 2019SOU EXTENSION 1 GRANTED
Monday, March 25, 2019SOU EXTENSION 1 FILED
Monday, March 25, 2019TEAS EXTENSION RECEIVED
Tuesday, January 22, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 25, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, October 21, 2018ASSIGNED TO LIE
Tuesday, October 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 5, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 4, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 4, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 8, 2018NON-FINAL ACTION E-MAILED
Wednesday, August 8, 2018NON-FINAL ACTION WRITTEN
Tuesday, August 7, 2018ASSIGNED TO EXAMINER
Thursday, April 26, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 21, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

granite research development pharmaceutical cancer field treatment analysis namely scientific genomic